Project Grant R01AG083756

Award Date 6/1/24
Completion Date 2/28/29
Dollars Obligated $3M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $608,731 to Brown University to study the impact of Medicare and Medicaid financial policies on post-acute and long-term care utilization and outcomes for persons living with Alzheimer's disease and related dementias (ADRD). The 5-year project aims to leverage Medicare claims and clinical assessment data to examine: 1) changes in nursing home and home health service use by ADRD patients amid...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
The Project Grant award R01AG087243, totaling $3,374,303 and awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), will fund the "Understanding Ambulatory Care Utilization in Alzheimer's Disease and Related Dementias (ACUA)" project. This project aims to investigate the role of fragmented ambulatory care in the diagnosis and management of people living with dementia. The key products and services to be delivered include: Secondary analyses of two NIA-funded...
This Project Grant award, titled "Care for Persons with Dementia in Medicare Advantage and Traditional Medicare: Family Spillovers and Disparities", is funded by the National Institute on Aging (CFDA 93.866 - Aging Research) for $2,462,393 with a project period from August 15, 2024 to April 30, 2029. The grant aims to study healthcare utilization and intergenerational transfers among Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD), comparing experiences...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $584,820 to support a 5-year research study led by Dr. Whitley Aamodt at the University of Pennsylvania. The goal is to improve end-of-life (EOL) care quality for hospitalized patients with Lewy body disorders, a type of Alzheimer's disease and related dementia (ADRD). The project has two key objectives: 1) develop a risk prediction model to identify patients at high risk of 6-month mortality,...
This $121,209 National Institute on Aging project grant will support research assessing the impact of primary care structural capabilities on hospitalizations among older adults with dementia. Specifically, the grantee will analyze cross-sectional data from 2018-2019 to describe structural capabilities like care coordination, electronic health records, and community integration in primary care practices employing nurse practitioners to serve Medicare beneficiaries with Alzheimer's disease and...
This Project Grant award of $2,763,221 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to examine the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on days spent at home among persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The study, conducted by Cedars-Sinai Medical Center, will use Medicare data linked to other nationally representative...
This $680,931 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a comprehensive research study to address disparities in nursing home care for people with serious mental illness (SMI) and Alzheimer's disease/related dementias (AD/ADRD). The key objectives are to: 1) Assess longitudinal patterns of SMI, AD/ADRD, and comorbid prevalence in nursing homes, including differences by race/ethnicity; 2) Estimate quality of life and quality of care...
This is a Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The total funding amount is $810,484, and the award period is from September 1, 2024 to May 31, 2028. The grant is funding research to examine racial and ethnic disparities in access to Alzheimer's Special Care Units (SCUs) in nursing homes, and how differences in SCU access contribute to disparities in health outcomes for Black and Hispanic residents with...
This Project Grant award of $2,278,636.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research to characterize and evaluate different nursing home clinician care models for residents with Alzheimer's disease and related dementias (ADRD). The project aims to understand the characteristics and outcomes of existing clinician care models, with a focus on the degree of co-management between nurse practitioners and physicians. The research will survey a nationally...

LONG-TERM CARE INTEGRATION FOR DUALLY ELIGIBLE INDIVIDUALS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS - PROJECT SUMMARY: A LACK OF COORDINATION BETWEEN MEDICARE AND MEDICAID SERVICES CREATES A FRAGMENTED CARE SYSTEM FOR DUALLY ELIGIBLE BENEFICIARIES AND CAN INCREASE THEIR RISK FOR POOR HEALTH OUTCOMES. DUALLY ELIGIBLE INDIVIDUALS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD) ARE EXCEPTIONALLY VULNERABLE UNDER THIS FRAGMENTED CARE SYSTEM. THEY OFTEN NEED EXTENSIVE ACUTE CARE (PAID BY MEDICARE) AND LONG-TERM CARE (PAID BY MEDICAID) BUT EXPERIENCE FUNCTIONAL AND COGNITIVE DECLINES, WHICH COMPOUND THE CHALLENGES OF NAVIGATING THE COMPLEX, BIFURCATED SYSTEMS OF MEDICARE AND MEDICAID. INTEGRATING MEDICAID-PAID LONG-TERM CARE INTO MEDICARE SERVICES (TERMED "LONG-TERM CARE INTEGRATION" HEREAFTER) CAN IMPROVE CARE COORDINATION FOR DUALLY ELIGIBLE INDIVIDUALS WITH ADRD. UNDER LONG-TERM CARE INTEGRATION, PEOPLE RECEIVE MEDICAID-PAID LONG-TERM CARE AND MEDICARE SERVICES FROM THE SAME INSURANCE COMPANY. IN THIS CASE, THE SINGLE COMPANY BEARS FINANCIAL RISK FOR BOTH MEDICARE SERVICES AND MEDICAID LONG- TERM CARE AND IS THEREFORE INCENTIVIZED TO COORDINATE MEDICARE SERVICES AND MEDICAID LONG-TERM CARE. A COMMON MECHANISM FOR LONG-TERM CARE INTEGRATION IS THE DUAL-ELIGIBLE SPECIAL NEEDS PLAN (D-SNP). LONG-TERM CARE INTEGRATION OCCURS THROUGH D-SNPS IN TWO WAYS. FIRST, SOME D-SNPS BEAR FINANCIAL RISK FOR BOTH MEDICARE SERVICES AND MEDICAID LONG-TERM CARE (WHICH WE REFER TO AS "SINGLE-CAPITATED D-SNPS"). SECOND, PEOPLE CAN RECEIVE MEDICARE SERVICES FROM A D-SNP AND LONG-TERM CARE FROM A SEPARATE MANAGED CARE PLAN, BOTH OF WHICH ARE OPERATED BY THE SAME PARENT INSURANCE COMPANY (WHICH WE REFER TO AS "ALIGNED D-SNP"). D-SNPS IS A SIGNIFICANT FORCE IN LONG-TERM CARE INTEGRATION, WITH SUBSTANTIAL INCREASES IN ENROLLMENTS IN SINGLE-CAPITATED OR ALIGNED D-SNPS OVER THE PAST DECADE. RECOGNIZING THEIR IMPORTANCE, CONGRESS PERMANENTLY AUTHORIZED AND REFINED THE UTILIZATION OF THE D-SNP FOR LONG-TERM CARE INTEGRATION IN 2018. HOWEVER, THIS RAPID ADOPTION OF THE D-SNP FOR LONG-TERM CARE INTEGRATION LACKS RIGOROUS EMPIRICAL EVIDENCE. OUR LONG-TERM GOAL IS TO PROVIDE A RIGOROUS EMPIRICAL EVALUATION OF SINGLE-CAPITATED AND ALIGNED D- SNPS, ULTIMATELY SUPPORTING EVIDENCE-BASED POLICIES THAT CAN IMPROVE OUTCOMES FOR DUALLY ELIGIBLE INDIVIDUALS WITH ADRD. LEVERAGING 2018-2024 MEDICARE CLAIMS LINKED WITH MEDICAID CLAIMS, THIS PROPOSAL WILL ADOPT A STAGGERED DIFFERENCE-IN-DIFFERENCES APPROACH TO OBTAIN THE CAUSAL EFFECTS OF SINGLE-CAPITATED AND ALIGNED D- SNPS ON KEY OUTCOMES. WE WILL ACCOMPLISH THREE AIMS. FIRST, WE ASSESS THE EFFECT OF SINGLE-CAPITATED D-SNPS. SECOND, WE ASSESS THE EFFECT OF ALIGNED D-SNPS AND COMPARE THE EFFECT OF ALIGNED VS SINGLE-CAPITATED D- SNPS. THIRD, WE ASSESS THE EFFECT OF ALIGNED D-SNPS BY PLAN CHARACTERISTICS. AS AN INCREASING NUMBER OF DUALLY ELIGIBLE INDIVIDUALS CONTINUE TO ENROLL IN SINGLE-CAPITATED OR ALIGNED D- SNPS, OUR STUDY WILL PROVIDE URGENTLY NEEDED INFORMATION ABOUT THE EFFECTS OF SINGLE-CAPITATED AND ALIGNED D- SNPS FOR DUALLY ELIGIBLE INDIVIDUALS WITH ADRD.

Posted 5/30/24